Sports supplement brand MuscleTech has unveiled its latest product, Peptide 185. The offering is fueled by dileucine, an ingredient the company says significantly increases the body’s ability to build muscle.
There is compelling evidence to support intake of leucine-enhanced amino acid supplements alongside low-level exercise to reduce sarcopenia in older female haemodialysis (HD) patients, according to latest research.
A new cross-sectional study reports that only 23% of type 2 diabetic patients aged 65 and over met their daily protein recommended intakes, suggesting a large source of frailty and sarcopenia seen in this population and highlighting potential intervention...
A group of experts in Asia has finalised 14 consensus statements around muscle health in healthy elderly and those suffering from sarcopenia, including recommendation for protein, leucine, and L-carnitine supplementation.
A new study provides further evidence to suggest that international recommendations for leucine intakes are not high enough to counteract muscle wasting in elderly people.
A new dileucine ingredient that leads to over 40% more muscle building potential than leucine alone is being commercialized by start-up Ingenious Ingredients, with the company already “vetting exclusive top-tier distribution and marketing partners”.
A novel combination of two Lactobacillus paracasei strains may increase absorption of key amino acids in plant proteins, according to a new placebo-controlled, randomized, double-blind, multicenter, crossover study.